Curve Therapeutics strengthens Leadership Team with appointment of experienced biotech executive Simon Jones
- Accomplished CFO and COO with proven track record in the biotech and pharmaceutical industry
- Strengthens Curve’s Leadership Team following £40.5 million Series A financing
Southampton, UK, 9 July 2024 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the appointment of Simon Jones as Chief Financial Officer (CFO) and Chief Operating Officer (COO).
